Cargando…

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy

Innate lymphocyte cells (ILCs), a novel family of innate immune cells are considered to function as key orchestrators of immune defences at mucosal surfaces and to be crucial for maintaining an intact intestinal barrier. Accordingly, first data suggest depletion of ILCs to be involved in human immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Krämer, Benjamin, Goeser, Felix, Lutz, Philipp, Glässner, Andreas, Boesecke, Christoph, Schwarze-Zander, Carolynne, Kaczmarek, Dominik, Nischalke, Hans Dieter, Branchi, Vittorio, Manekeller, Steffen, Hüneburg, Robert, van Bremen, Tobias, Weismüller, Tobias, Strassburg, Christian P., Rockstroh, Jürgen K., Spengler, Ulrich, Nattermann, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444854/
https://www.ncbi.nlm.nih.gov/pubmed/28505204
http://dx.doi.org/10.1371/journal.ppat.1006373
_version_ 1783238781572218880
author Krämer, Benjamin
Goeser, Felix
Lutz, Philipp
Glässner, Andreas
Boesecke, Christoph
Schwarze-Zander, Carolynne
Kaczmarek, Dominik
Nischalke, Hans Dieter
Branchi, Vittorio
Manekeller, Steffen
Hüneburg, Robert
van Bremen, Tobias
Weismüller, Tobias
Strassburg, Christian P.
Rockstroh, Jürgen K.
Spengler, Ulrich
Nattermann, Jacob
author_facet Krämer, Benjamin
Goeser, Felix
Lutz, Philipp
Glässner, Andreas
Boesecke, Christoph
Schwarze-Zander, Carolynne
Kaczmarek, Dominik
Nischalke, Hans Dieter
Branchi, Vittorio
Manekeller, Steffen
Hüneburg, Robert
van Bremen, Tobias
Weismüller, Tobias
Strassburg, Christian P.
Rockstroh, Jürgen K.
Spengler, Ulrich
Nattermann, Jacob
author_sort Krämer, Benjamin
collection PubMed
description Innate lymphocyte cells (ILCs), a novel family of innate immune cells are considered to function as key orchestrators of immune defences at mucosal surfaces and to be crucial for maintaining an intact intestinal barrier. Accordingly, first data suggest depletion of ILCs to be involved in human immunodeficiency virus (HIV)-associated damage of the intestinal mucosa and subsequent microbial translocation. However, although ILCs are preferentially localized at mucosal surfaces, only little is known regarding distribution and function of ILCs in the human gastrointestinal tract. Here, we show that in HIV(-) individuals composition and functional capacity of intestinal ILCs is compartment-specific with group 1 ILCs representing the major fraction in the upper gastrointestinal (GI) tract, whereas ILC3 are the predominant population in ileum and colon, respectively. In addition, we present first data indicating that local cytokine concentrations, especially that of IL-7, might modulate composition of gut ILCs. Distribution of intestinal ILCs was significantly altered in HIV patients, who displayed decreased frequency of total ILCs in ileum and colon owing to reduced numbers of both CD127(+)ILC1 and ILC3. Of note, frequency of colonic ILC3 was inversely correlated with serum levels of I-FABP and sCD14, surrogate markers for loss of gut barrier integrity and microbial translocation, respectively. Both expression of the IL-7 receptor CD127 on ILCs as well as mucosal IL-7 mRNA levels were decreased in HIV(+) patients, especially in those parts of the GI tract with reduced ILC frequencies, suggesting that impaired IL-7 responses of ILCs might contribute to incomplete reconstitution of ILCs under effective anti-retroviral therapy. This is the first report comparing distribution and function of ILCs along the intestinal mucosa of the entire human gastrointestinal tract in HIV(+) and HIV(-) individuals.
format Online
Article
Text
id pubmed-5444854
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54448542017-06-06 Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy Krämer, Benjamin Goeser, Felix Lutz, Philipp Glässner, Andreas Boesecke, Christoph Schwarze-Zander, Carolynne Kaczmarek, Dominik Nischalke, Hans Dieter Branchi, Vittorio Manekeller, Steffen Hüneburg, Robert van Bremen, Tobias Weismüller, Tobias Strassburg, Christian P. Rockstroh, Jürgen K. Spengler, Ulrich Nattermann, Jacob PLoS Pathog Research Article Innate lymphocyte cells (ILCs), a novel family of innate immune cells are considered to function as key orchestrators of immune defences at mucosal surfaces and to be crucial for maintaining an intact intestinal barrier. Accordingly, first data suggest depletion of ILCs to be involved in human immunodeficiency virus (HIV)-associated damage of the intestinal mucosa and subsequent microbial translocation. However, although ILCs are preferentially localized at mucosal surfaces, only little is known regarding distribution and function of ILCs in the human gastrointestinal tract. Here, we show that in HIV(-) individuals composition and functional capacity of intestinal ILCs is compartment-specific with group 1 ILCs representing the major fraction in the upper gastrointestinal (GI) tract, whereas ILC3 are the predominant population in ileum and colon, respectively. In addition, we present first data indicating that local cytokine concentrations, especially that of IL-7, might modulate composition of gut ILCs. Distribution of intestinal ILCs was significantly altered in HIV patients, who displayed decreased frequency of total ILCs in ileum and colon owing to reduced numbers of both CD127(+)ILC1 and ILC3. Of note, frequency of colonic ILC3 was inversely correlated with serum levels of I-FABP and sCD14, surrogate markers for loss of gut barrier integrity and microbial translocation, respectively. Both expression of the IL-7 receptor CD127 on ILCs as well as mucosal IL-7 mRNA levels were decreased in HIV(+) patients, especially in those parts of the GI tract with reduced ILC frequencies, suggesting that impaired IL-7 responses of ILCs might contribute to incomplete reconstitution of ILCs under effective anti-retroviral therapy. This is the first report comparing distribution and function of ILCs along the intestinal mucosa of the entire human gastrointestinal tract in HIV(+) and HIV(-) individuals. Public Library of Science 2017-05-15 /pmc/articles/PMC5444854/ /pubmed/28505204 http://dx.doi.org/10.1371/journal.ppat.1006373 Text en © 2017 Krämer et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Krämer, Benjamin
Goeser, Felix
Lutz, Philipp
Glässner, Andreas
Boesecke, Christoph
Schwarze-Zander, Carolynne
Kaczmarek, Dominik
Nischalke, Hans Dieter
Branchi, Vittorio
Manekeller, Steffen
Hüneburg, Robert
van Bremen, Tobias
Weismüller, Tobias
Strassburg, Christian P.
Rockstroh, Jürgen K.
Spengler, Ulrich
Nattermann, Jacob
Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy
title Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy
title_full Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy
title_fullStr Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy
title_full_unstemmed Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy
title_short Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy
title_sort compartment-specific distribution of human intestinal innate lymphoid cells is altered in hiv patients under effective therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444854/
https://www.ncbi.nlm.nih.gov/pubmed/28505204
http://dx.doi.org/10.1371/journal.ppat.1006373
work_keys_str_mv AT kramerbenjamin compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT goeserfelix compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT lutzphilipp compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT glassnerandreas compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT boeseckechristoph compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT schwarzezandercarolynne compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT kaczmarekdominik compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT nischalkehansdieter compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT branchivittorio compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT manekellersteffen compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT huneburgrobert compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT vanbrementobias compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT weismullertobias compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT strassburgchristianp compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT rockstrohjurgenk compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT spenglerulrich compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy
AT nattermannjacob compartmentspecificdistributionofhumanintestinalinnatelymphoidcellsisalteredinhivpatientsundereffectivetherapy